Advancements in Mesenchymal Stem Cell-Based Therapy for Enhancing Arteriovenous Fistula Patency
Gaurav Baranwal, Haseeb Mukhtar, Jamie Kane, Alaura Lemieux, Sanjay Misra, Mirjana Jerkic · 2024
Read Advancements in Mesenchymal Stem Cell-Based Therapy for Enhancing Arteriovenous Fistula Patency by Gaurav Baranwal, Haseeb Mukhtar, Jamie Kane, Alaura Lemieux, Sanjay Misra, Mirjana Jerkic (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11641758.txt.
Description
Gaurav Baranwal and co-authors review stem cell therapy to keep dialysis access open in a 2024 paper. Kidney disease affects more than a tenth of the world. For dialysis, a fistula joins an artery and vein, but many fistulas fail within the first year.
Mesenchymal stem cells are studied as a way to heal and protect these access points. The review covers cell sources, from fetal to adult tissue, and past work on markers, immune cells, and low oxygen. It weighs how cell therapy might cut repeat procedures for patients. The field is still young, so the review maps both promise and gaps.
Catalog record
| CREATOR | Gaurav Baranwal, Haseeb Mukhtar, Jamie Kane, Alaura Lemieux, Sanjay Misra, Mirjana Jerkic |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |